SCHEMBL4409028

SCHEMBL4409028

OCC[C@@H](O)[C@H](O)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL283543 1.00
SCHEMBL13062506 1.00
SCHEMBL346604 1.00
SCHEMBL9564560 1.00
SCHEMBL4409027 1.00
SCHEMBL8927312 0.91 THRB (0.43)
SCHEMBL13669944 0.89 THRB (0.50)
SCHEMBL1491969 0.89 THRB (0.50)
SCHEMBL26509369 0.89 THRB (0.50)
E968 SCHEMBL5202199 0.87 THRB (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119510372-A Screening and preparation method of anti-aging product formula 朱颜(深圳)生物科技有限公司 2025-02-25 CN claimed
WO-2022256467-A1 COMPOSITIONS AND METHODS COMPRISING DEOXY-PENTITOLS THE CHARLOTTE MECKLENBURG HOSPITAL AUTHORITY D/B/A ATRIUM HEALTH (US) 2022-12-08 WO claimed
US-8642644-B2 Ophthamological drugs DUKE UNIVERSITY (US) 2014-02-04 US claimed
US-20090318542-A1 OPHTHAMOLOGICAL DRUGS DUKE UNIVERSITY 2009-12-24 US claimed
EP-1812017-A2 OPHTHAMOLOGICAL DRUGS Duke University (US) 2007-08-01 EP claimed
US-20060135609-A1 Ophthamological drugs DUKE UNIVERSITY (US) 2006-06-22 US claimed
WO-2006047466-A2 OPHTHAMOLOGICAL DRUGS DUKE UNIVERSITY (US) 2006-05-04 WO claimed
US-20250241869-A1 COMPOSITIONS AND METHODS COMPRISING DEOXY-PENTITOLS THE CHARLOTTE MECKLENBURG HOSPITAL AUTHORITY D/B/A ATRIUM HEALTH (US) 2025-07-31 US disclosed
US-12257214-B2 Compositions and methods comprising deoxy-pentitols THE CHARLOTTE MECKLENBURG HOSPITAL AUTHORITY (US) 2025-03-25 US disclosed
CN-119510372-A Screening and preparation method of anti-aging product formula 朱颜(深圳)生物科技有限公司 2025-02-25 CN disclosed
US-20220387346-A1 COMPOSITIONS AND METHODS COMPRISING DEOXY-PENTITOLS THE CHARLOTTE MECKLENBURG HOSPITAL AUTHORITY D/B/A ATRIUM HEALTH 2022-12-08 US disclosed
WO-2022256467-A1 COMPOSITIONS AND METHODS COMPRISING DEOXY-PENTITOLS THE CHARLOTTE MECKLENBURG HOSPITAL AUTHORITY D/B/A ATRIUM HEALTH (US) 2022-12-08 WO disclosed
US-20160081336-A1 MEDIUM WITH A PLANT NON-METABOLIZABLE SUGAR FOR IMPROVING SEED GERMINATION WEYERHAEUSER NR COMPANY (US) 2016-03-24 US disclosed
US-6468688-B2 CHARGING, DISCHARGING EFFICIENCY; VANADIUM ELECTROLYTE PINNACLE VRB LIMITED (AU) 2002-10-22 US disclosed
US-20010028977-A1 Charging, discharging efficiency; vanadium electrolyte JD HOLDING INC. (KY) 2001-10-11 US disclosed
US-6143443-A ALL-VANADIUM REDOX BATTERY, COMPRISING THE STABILIZED ELECTROLYTE PINNACLE ARB LIMITED (AU) 2000-11-07 US disclosed
EP-0729648-A4 STABILISED ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND REDOX CELLS AND BATTERIES CONTAINING STABILISED ELECTROLYTE SOLUTIONS UNISEARCH LTD (AU) 1997-01-02 EP disclosed
EP-0729648-A1 STABILISED ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND REDOX CELLS AND BATTERIES CONTAINING STABILISED ELECTROLYTE SOLUTIONS UNISEARCH LIMITED (AU) 1996-09-04 EP disclosed
WO-1995012219-A1 STABILISED ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND REDOX CELLS AND BATTERIES CONTAINING STABILISED ELECTROLYTE SOLUTIONS UNISEARCH LIMITED (AU) 1995-05-04 WO disclosed
EP-0450585-A2 Process for the manufacture of 2-deoxy-D-threo-pentofuranosides, intermediates for their manufacture and their use CHEMPROSA, CHEMISCHE PRODUKTE SAISCHEK GmbH (AT) 1991-10-09 EP disclosed